Home › NDC Lookup › Ingredients › Bos Taurus Gallbladder, Bryonia, Chelido... › 63479-0113-01
A13 DTX-LIVER BOS TAURUS GALLBLADDER, BRYONIA, CHELIDONIUM MAJUS, CHOLESTERINUM, HEPAR SULPHURIS CALCAREUM , JUNIPERUS COMMUNIS STEM, LYCOPODIUM CLAVATUM, NATRUM SULPHURICUM, PHOSPHORUS, RHAMNUS PURSHIANA, ROSMARINUS OFFICINALIS, SECALE CEREALE WHOLE 6 [hp_X]/mL; 30 [hp_X]/mL; 7 [hp_C]/mL; 7 [hp_C]/mL; 1 [hp_X]/mL; 1 [hp_X]/mL; 6 [hp_X]/mL; 3 [hp_X]/mL Solution/ Drops, 30 mL — NDC 63479-0113-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

A13 DTX-LIVER BOS TAURUS GALLBLADDER, BRYONIA, CHELIDONIUM MAJUS, CHOLESTERINUM, HEPAR SULPHURIS CALCAREUM , JUNIPERUS COMMUNIS STEM, LYCOPODIUM CLAVATUM, NATRUM SULPHURICUM, PHOSPHORUS, RHAMNUS PURSHIANA, ROSMARINUS OFFICINALIS, SECALE CEREALE WHOLE 6 [hp_X]/mL; 30 [hp_X]/mL; 7 [hp_C]/mL; 7 [hp_C]/mL; 1 [hp_X]/mL; 1 [hp_X]/mL; 6 [hp_X]/mL; 3 [hp_X]/mL Solution/ Drops, 30 mL — NDC 63479-0113-1 (Billing 63479-0113-01)

by Apex Energetics Inc. · 30 mL in 1 BOTTLE, GLASS

This is a package of 30 mL of A13 DTX-LIVER BOS TAURUS GALLBLADDER, BRYONIA, CHELIDONIUM MAJUS, CHOLESTERINUM, HEPAR SULPHURIS CALCAREUM , JUNIPERUS COMMUNIS STEM, LYCOPODIUM CLAVATUM, NATRUM SULPHURICUM, PHOSPHORUS, RHAMNUS PURSHIANA, ROSMARINUS OFFICINALIS, SECALE CEREALE WHOLE 6 [hp_X]/mL; 30 [hp_X]/mL; 7 [hp_C]/mL; 7 [hp_C]/mL; 1 [hp_X]/mL; 1 [hp_X]/mL; 6 [hp_X]/mL; 3 [hp_X]/mL Solution/ Drops from Apex Energetics Inc., marketed since Oct 1998 and currently FDA-listed. It is this product's only package size.

NDC 63479-0113-01
🏷️ FDA NDC (as labeled) 63479-0113-1 billing pads the package segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Oct 8, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 63479-0113-1 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
63479 labeler · 0113 product · 1 package
Package marketed since
Oct 15, 1998
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Barcode (UPC-A, from the NDC)
3 6347901131 2
FDA record last changed
Oct 8, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 63479-0113-1
Product NDC 63479-0113
11-digit billing NDC 63479011301
UNII T7J046YI2B, 27YLU75U4W, 9901V1E867, 1MBW07J51Q, HBU87MH6OY, 12M71ST1GZ +6 more
SPL Set ID bed751f5-a8da-cac7-e053-2a95a90a2218
Established class (EPC) Osmotic Laxative
Mechanism of action Osmotic Activity
Physiologic effect Increased Large Intestinal Motility; Inhibition Large Intestine Fluid/Electrolyte Absorption
DEA schedule Non-controlled
Marketing category UNAPPROVED HOMEOPATHIC
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 1998-10-15
Route SUBLINGUAL
Dosage form SOLUTION/ DROPS
Substance BRYONIA ALBA ROOT; PHOSPHORUS; BOS TAURUS GALLBLADDER; CALCIUM SULFIDE; JUNIPERUS COMMUNIS STEM; SECALE CEREALE WHOLE; SODIUM SULFATE; FRANGULA PURSHIANA BARK; ROSMARINUS OFFICINALIS FLOWERING TOP; CHELIDONIUM MAJUS; CHOLESTEROL; LYCOPODIUM CLAVATUM SPORE
Why two NDCs? The FDA registers this code as 63479-0113-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 63479-0113-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

This is an unapproved homeopathic solution taken as drops under the tongue. It contains multiple plant, mineral, and animal-derived ingredients that are traditionally used in homeopathic practice for liver and gallbladder support, though homeopathic products are not evaluated by the FDA for effectiveness. The ingredients include bovine gallbladder, bryonia, chelidonium, and other substances that appear in homeopathic formulations, along with minerals like phosphorus and sodium sulfate. Homeopathic products are marketed based on traditional homeopathic principles rather than established medical evidence.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
63479-0113-01 You're viewing this Main listing 30 mL in 1 BOTTLE, GLASS 1998-10-15 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
A13 Dtx-Liver 6 [hp_X]/mL; 30 [hp_X]/mL; 7 [hp_C]/mL; 7 [hp_C]/mL; 1 [hp_X]/mL; 1 [hp_X]/mL; 6 [hp_X]/mL; 3 [hp_X]/mLthis 63479-0113-01 Apex 30 ml — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
1998
On the market since
Oct 1998
📍
2026
Currently FDA-listed
28 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 3K9958V90M
    A liquid solvent derived from fermentation or chemical synthesis. In medicines, alcohol dissolves active ingredients, helps preserve the product, and improves how the body absorbs certain drugs.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

2 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesalcohol (20% by volume), distilled water

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerApex Energetics Inc.
Labeler code63479
First marketedOct 1998
Product typeHuman Otc Drug
Portfolio110 products on file

More NDCs from Apex Energetics Inc. labeler code 63479

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Other Information 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 29 words ▾

Uses: For temporary relief of minor: • tiredness* headaches* irritability* muscle pains* poor digestion* skin rash* *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

⏱️ Dosage and Administration 38 words ▾

Directions: Adults & children ages 12 years and over: Take 10 drops under the tongue 3 times a day, or as directed by your healthcare professional. Consult a physician for use in children under 12 years of age.

⚠️ Warnings 76 words ▾

Warnings: If pregnant or breastfeeding , ask a health professional before use. Do not use if clear seal over the cap is broken or missing. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Stop use and ask a doctor if tiredness, headaches, irritability, muscle pains, poor digestion, skin rash, or other symptoms do not improve within 7 days or are accompanied by fever.

🧪 Active Ingredient 49 words ▾

Active Ingredients Bos Taurus Gallbladder 7C Bryonia 6X Chelidonium Majus 4X 6X 9X 12X Cholesterinum 6X 9X 12X Hepar Sulphuris Calcareum 7C Juniperus Communis Stem 1X Lycopodium Clavatum 6X 9X 12X 30X Natrum Sulphuricum 6X Phosphorus 12X 15X 30X Rhamnus Purshiana 3X Rosmarinus Officinalis 1X Secale Cereale Whole 1X

🧪 Inactive Ingredients 8 words ▾

Inactive Ingredients alcohol (20% by volume), distilled water

🎯 Purpose 29 words ▾

Uses: For temporary relief of minor: • tiredness* headaches* irritability* muscle pains* poor digestion* skin rash* *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

📄 Stop Use and Ask a Doctor If 30 words ▾

Stop use and ask a doctor if tiredness, headaches, irritability, muscle pains, poor digestion, skin rash, or other symptoms do not improve within 7 days or are accompanied by fever.

🤰 If Pregnant or Breast-Feeding 11 words ▾

If pregnant or breastfeeding , ask a health professional before use.

📄 Keep Out of Reach of Children 21 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

📄 Other Information 13 words ▾

Do not use if clear seal over the cap is broken or missing.

📄 Questions or Comments 12 words ▾

Distributed by Apex Energetics. Questions? 16592 Hale Ave., Irvine, CA 92606, USA

📄 Package Label / Principal Display Panel 24 words ▾

FUTUREPLEX® A13 ANTITOX® DTX-LIVER™ Homeopathic Formula Tiredness* Headaches* Irritability* Muscle Pains* 1 fl oz (30 mL) Alcohol 20% by Volume A13 DTX-Liver 20201029 label.jpg

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for A13 DTX-LIVER (this brand).

Top reported reactions

Diarrhoea7
Decreased Appetite6
Pain5
Abdominal Pain4
Headache4
Malaise4
Vomiting4

Reporter sex

0 reports

Serious outcomes

Disabling7
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 4 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product Homeopathic listing

About homeopathic listings

A13 DTX-LIVER BOS TAURUS GALLBLADDER, BRYONIA, CHELIDONIUM MAJUS, CHOLESTERINUM, HEPAR SULPHURIS CALCAREUM , JUNIPERUS COMMUNIS STEM, LYCOPODIUM CLAVATUM, NATRUM SULPHURICUM, PHOSPHORUS, RHAMNUS PURSHIANA, ROSMARINUS OFFICINALIS, SECALE CEREALE WHOLE 6 [hp_X]/mL; 30 [hp_X]/mL; 7 [hp_C]/mL; 7 [hp_C]/mL; 1 [hp_X]/mL; 1 [hp_X]/mL; 6 [hp_X]/mL; 3 [hp_X]/mL SOLUTION/ DROPS is listed under the homeopathic marketing category. An NDC listing in this category does not by itself establish FDA approval, and FDA does not evaluate homeopathic products for effectiveness. This page reports the listing data as published.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Homeopathic". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Apex Energetics Inc.. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Apex Energetics Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 63479-0112-01 · Apex 63479-0114-01 · Apex →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.